Rafal Kowalczyk

VP, Head of Finance, Facilities, Lab Ops at Sail Biomedicines

Speaker

Rafal Kowalczyk is Vice President, Head of Finance for Sail Biomedicines, a Flagship Pioneering Company. He held the same role at Senda Biosciences pre-merger of two Flagship Portfolio Companies, and bringing almost two decades of experience across multiple private and public biotech startups, the pharmaceutical industry and the defense industry.

Rafal is responsible for Financial Planning and Analysis, Accounting and Financial Operations, playing a key role in the financial and strategic steering of the organization.

Rafal has served in senior financial roles at Passage Bio, Spark Therapeutics (acquired by Roche), as well as AstraZeneca. Before his career in industry, Rafal led Finance roles at United Technologies (now Raytheon Technologies). Rafal holds an M.B.A. in Finance & Entrepreneuri­alism from Northeastern University and a B.S. in Finance from Quinnipiac University.